Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets

Fig. 3

Capability of baseline galectin-3 to predict RA development in patients initially classified with UA. ROC curve analysis was used to assess the ability of galectin-3 alone (a) or in combination with anti-CCP (b) to distinguish between UA patients who will and those who will not develop RA within 12–23 months follow-up. UA: undifferentiated arthritis.. Anti-CCP antibodies to cyclic citrullinated peptides, AUC area under curve

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us